About Us

Revogenex, Inc., a specialty pharmaceutical development company, is dedicated to delivering quality and speed in pharmaceutical product development. 

Established in 2009 through the acquisition of an existing successful pharmaceutical development company, we are focused on the development of 505 (b)(2) NDA drugs that address a wide range of specialty therapeutic areas. 

Our development efforts span from the product’s conceptualization, formulation, analytical, clinical development, regulatory development completely through ultimate NDA approval.  We partner our products with proven sales and marketing organizations for commercialization.

We are an entrepreneurial organization that devotes extensive efforts to continually improve the way we do business.  Our global platform currently comprises the USA, Ireland and India with plans for growth in those areas along with establishing capabilities in China.  Our corporate headquarters are located in Duluth, Georgia.